The gas-to-hydrogen technology developer bagged $11.5m in funding to commercialise technology developer at UC Santa Barbara.

The financial services and insurance group had initially earmarked about $100m for strategic investments in 2017 and has since backed 25 companies.

We remember George Shultz, former University of Chicago Booth School of Business professor and dean.

Alphabet's GV unit and Huami both took part as the portable MRI device developer completed an oversubscribed series D round.

Marubeni Ventures helped the online fresh food supplier push its overall funding past the $240m mark as it looks to expand further across the United States.

A round up of the week's new fund and incbuator launches.

Cleva Pharma Capital backed a series C round that will support the clinical progress of drug candidates for sensorineural hearing loss and multiple sclerosis.

Returning backer Novo was among the investors in a series C round for the synthetic cancer treatment developer that was led by RA Capital Management.

The vehicle charging technology developer, which counts Sumitomo, LG Chem, Samsung, Bangchak and Lenovo as investors, has now raised $191m in total.

Today's deal net contains news from RAW Labs, Neuropain Therapeutics and Swajal.